GNC Sales Remain HEALTHY and 4 Fresh Analyst Insights

Molina Healthcare Inc. (NYSE:MOH) and Centene (NYSE:CNC) shares are forecast by Deutsche Bank to experience a bit of near-term weakness, following a move on Tuesday by an Ohio judge to temporarily blocked the State’s Medicaid agency from initiating their new Medicaid contracts, subsequent to a legal claim by Aetna (NYSE:AET).

Don’t Miss: ARENA BLOWS UP! First Weight-Loss Drug Approved in 13 Years.

Zynga’s (NASDAQ:ZNGA) price target was lowered by Macquarie, as it pointed out limited visibility, a lack of near-term catalysts, and uncertainty concerning its longer-term strategic positioning. Shares remain rated as Neutral.

Dollar General Corporation (NYSE:DG) had its price target increased by Deutsche Bank following its investor day, while retaining its Buy rating.

GNC Holdings Inc (NYSE:GNC) sales remain quite healthy, says Deutsche Bank, and the analysts also think that DMAA recall risk is overstated, following channel checks. DB also believes that GNC shares look very attractive at their current levels and maintains its Buy along with a $46 price target.

NetApp, Inc. (NASDAQ:NTAP) is said by Piper Jaffray to not be a ‘broken story, subsequent to its analyst event on Tuesday. Piper considers that shares remain attractive at their current levels and restates its Overweight, with a price target of $35.

Don’t Miss: Apple is Turning the Page on Mobile Screens: Think 3D!

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.